Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of FCRN antagonists for treatment of generalized myasthenia gravis

Use of FCRN antagonists for treatment of generalized myasthenia gravis

US Patent 12240875 · Granted Mar 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FcRn/HSA binding molecules and methods of use2025
Compositions and methods for treating immune thrombocytopenia2025
Compositions and methods for treating immune thrombocytopenia2025
Compositions and methods for treating immune thrombocytopenia2025
Method of preparing pH-dependent antibodies2024
IL-6 binding molecules2023
IL-6 binding molecules2023
CD70 combination therapy2023
CD70 combination therapy2023
Asymmetric multispecific antibodies2023
FcRn antagonists and methods of use2022
FcRn antagonists and methods of use2022